ArticleMolecular medicine reports2018

Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.

Yiqiao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.